NCT06353386: An ongoing trial by Merck Sharp & Dohme LLC
This trial is ongoing. It must report results 4 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06353386 |
|---|---|
| Title | MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Combinations or MK-5684 Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 20, 2024 |
| Completion date | Jan. 15, 2029 |
| Required reporting date | Jan. 15, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |